Form D · Pharmaceuticals
Taxus Pharmaceuticals, Inc.
Jinzhong, F4 · CIK 0001549065
Offering snapshot reported May 10, 2012 · SEC filing
- Reported sold
- $3.62K Offering amount: $3.62K
- Investors reported
- 35 Form D · investor count
- Minimum accepted
- $100 Reported outside-investor minimum
- First sale
- Mar 22, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 10, 2012 | Initial | $3,620 | No comparison | 35 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 05
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-178016
Source: Form D, filed May 10, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Zhixin Li | Director |
| Jiayue Zhang | Director, Executive |
| Hong Zhang | Director |
| Tong Zhang | Director, Executive |
| Xiaoxing Zhang | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Room 1202, 12 Th Floor Jin Shang International Golden Tower
Jinzhong, F4, 030600
Jinzhong, F4, 030600